V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010825 | 310005529 | 1.63 | 80 | Palliative (P) | 2017-11-11 | 2017-11-13 | EOX | N | N | 310012966 | DACARBAZINE |
| 310010826 | 310008449 | 1.59 | 62.2 | Disease modification (D) | null | 2017-07-27 | CAPECITABINE + OXALIPLATIN | Y | null | 310013066 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 310010827 | 310005535 | 1.54 | 56.8 | Palliative (P) | null | 2014-09-26 | MITOMYCIN | N | N | 310013139 | CISPLATIN + TOPOTECAN |
| 310010828 | 310008452 | 1.64 | 49 | Curative (C) | 2016-12-28 | 2016-12-30 | Bevacizumab+Carbo+Gemcitabine | N | N | 310013310 | CAPECITABINE + CISPLATIN |
| 310010829 | 310008453 | null | 58.9 | Palliative (P) | 2018-10-20 | 2018-11-25 | ECX | N | N | 310013706 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310010830 | 310005546 | 1.68 | 57.6 | Palliative (P) | 2014-07-10 | 2014-07-10 | Trabectedin | 02 | Y | 310015515 | CHLORAMBUCIL + DEXAMETHASONE + ETOPOSIDE |
| 310010831 | 310005553 | 1.68 | 0 | Palliative (P) | 2016-11-06 | 2017-02-28 | ICON8 TRIAL | 02 | null | 310016521 | FEC |
| 310010832 | 310005558 | null | null | Adjuvant (A) | 2019-06-24 | 2019-06-24 | Thalidomide 100mg | N | N | 310018382 | METHOTREXATE HIGH DOSE |
| 310010833 | 310005560 | 1.7 | 82.3 | Curative (C) | 2018-04-23 | 2018-04-23 | Cisplatin + Etoposide (3 day) | N | null | 310018395 | THALIDOMIDE |
| 310010834 | 310005564 | 1.96 | 52 | Palliative (P) | 2016-03-07 | 2017-08-01 | R GCVP | N | N | 310018837 | PEG INTERFERON |
| 310010835 | 310005570 | 1.61 | 67.4 | Palliative (P) | 2019-04-01 | 2019-04-08 | Irinotecan + Modified De Gramont | N | N | 310020027 | FLUDARABINE + MELPHALAN |
| 310010836 | 310008471 | 1.77 | null | Curative (C) | 2013-09-15 | 2017-07-10 | Capecitabine | 02 | N | 310020428 | ECX |
| 310010837 | 310011338 | 1.67 | 64.5 | Neo-adjuvant (N) | 2017-01-23 | 2017-01-23 | Paclitaxel albumin (Abraxane) 21day | Y | N | 310020916 | UKALL2014 |
| 310010838 | 310005573 | 1.59 | 46.7 | Adjuvant (A) | 2018-01-05 | 2018-01-08 | EC | 2 | null | 310021204 | IFOSFAMIDE |
| 310010839 | 310008473 | 1.61 | 64.5 | Palliative (P) | 2017-02-20 | 2017-06-06 | IVE + METHOTREXATE | N | N | 310021471 | TOPOTECAN |
| 310010840 | 310005579 | 1.68 | null | Palliative (P) | 2012-12-25 | 2014-12-23 | BCG Intravesical | N | null | 310021589 | AZACITIDINE |
| 310010841 | 310008477 | null | 70.4 | Palliative (P) | 2015-12-03 | 2016-06-27 | CHOEP | null | null | 310021779 | IFOSFAMIDE |
| 310010842 | 310008477 | 1.73 | 81 | Disease modification (D) | 2017-10-28 | 2017-10-30 | FLUOROURACIL + IRINOTECAN | 02 | N | 310021779 | ALEMTUZUMAB |
| 310010843 | 310005586 | 1.72 | 76.5 | Curative (C) | 2016-01-18 | 2016-01-28 | CHOEP | N | N | 310022205 | PEG INTERFERON |
| 310010844 | 310005589 | 1.68 | 54.5 | Not known (9) | 2017-07-16 | 2017-08-11 | ECHELON-2 TRIAL | null | null | 310022506 | BEVACIZUMAB + CAPECITABINE |
| 310010845 | 310005591 | 1.96 | 85.45 | Curative (C) | 2016-01-09 | 2016-01-17 | RUXOLITINIB | 02 | N | 310022562 | BEAM + FLUDARABINE |
| 310010846 | 310005594 | 1.82 | 68 | Adjuvant (A) | 2014-11-06 | 2015-03-24 | Lenalidomide Cycle 26 onwards (PAS) | 02 | N | 310022639 | ABIRATERONE |
| 310010847 | 310005597 | 1.7 | 87.4 | Palliative (P) | 2015-09-09 | 2015-09-09 | DABRAFENIB | 2 | N | 310022751 | ARSENIC TRIOXIDE + ATRA |
| 310010848 | 310005599 | 1.6 | 74.8 | Curative (C) | 2014-08-16 | 2014-08-16 | Gemcitabine + Oxaliplatin | null | N | 310022763 | BEAM + ALEMTUZUMAB |
| 310010849 | 310005602 | 1.67 | 73.8 | Palliative (P) | 2019-03-25 | 2019-04-20 | R GCVP | N | null | 310022819 | DOXORUBICIN |
| 310010850 | 310008490 | 1.82 | 76.8 | Palliative (P) | 2016-10-31 | 2017-04-15 | Methotrexate High Dose (3g/m2) | N | N | 310022826 | RUXOLITINIB |
| 310010851 | 310005606 | null | 37.4 | Palliative (P) | 2019-06-18 | 2019-06-18 | ALL Int GdeC EscCapMaint PhIII PAsp | N | N | 310022924 | CETUXIMAB + IRINOTECAN + MDG |
| 310010852 | 310010867 | 0 | null | Curative (C) | 2017-04-01 | 2017-05-13 | FEC 100 | null | null | 310022967 | TRABECTEDIN |
| 310010853 | 310011343 | 1.63 | 72.8 | Palliative (P) | 2018-08-17 | 2020-03-01 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 310023035 | DABRAFENIB |
| 310010854 | 310005614 | 1.57 | 25.8 | Neo-adjuvant (N) | 2016-11-26 | 2017-04-16 | R GCVP | N | N | 310023219 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310010855 | 310011936 | 0 | 61.5 | Palliative (P) | 2017-11-21 | 2017-11-25 | Olaparib | null | N | 310023406 | IVE + METHOTREXATE |
| 310010856 | 310005616 | null | null | Palliative (P) | 2015-12-14 | 2016-04-26 | CISPLATIN + FLUOROURACIL | N | Y | 310023408 | CAPECITABINE + OXALIPLATIN |
| 310010857 | 310010034 | 1.79 | null | null | 2014-10-07 | 2015-09-22 | Cetuximab 7 day (Cycle 1) | 2 | null | 310023408 | CETUXIMAB + RT |
| 310010858 | 310005622 | 1.85 | 85.6 | Palliative (P) | 2017-05-25 | 2017-06-29 | TRASTUZUMAB | N | N | 310023655 | CYCLOPHOSPHAMIDE + VINBLASTINE |
| 310010859 | 310005635 | null | 86.4 | Curative (C) | 2017-12-11 | 2018-04-03 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | N | 310024235 | RMS 2005 TRIAL |
| 310010860 | 310005638 | null | 118 | Not known (9) | 2017-10-30 | 2018-04-10 | Capecitabine (21 day) + Irinotecan | 02 | N | 310024263 | VEDEX |
| 310010861 | 310005642 | 1.75 | 65 | null | 2014-04-20 | 2014-04-21 | PEG INTERFERON | 02 | N | 310024340 | OXALIPLATIN + MDG |
| 310010862 | 310005647 | null | 71 | Curative (C) | 2018-02-15 | 2018-08-02 | Triple / Double Intrathecal Therapy | N | N | 310024565 | IVA |
| 310010863 | 310005652 | null | null | Palliative (P) | 2018-02-16 | 2018-02-16 | EOX | N | N | 310024857 | ERLOTINIB |
| 310010864 | 310005657 | 1.62 | 73 | Palliative (P) | 2018-03-03 | 2018-11-02 | CVD | N | N | 310025026 | ICE |
| 310010865 | 310005659 | 1.81 | 74 | Curative (C) | null | 2014-12-23 | IBRUTINIB | N | N | 310025101 | ECF |
| 310010866 | 310010043 | 1.7 | 79.4 | Palliative (P) | 2019-01-05 | 2019-01-07 | ICE (no GCSF) | N | Y | 310025220 | IVE + METHOTREXATE |
| 310010867 | 310010043 | 1.78 | 78.6 | Palliative (P) | 2017-01-08 | 2017-05-02 | DOXORUBICIN | N | N | 310025220 | BLEOMYCIN |
| 310010868 | 310005663 | 1.67 | 78 | Palliative (P) | 2018-03-11 | 2018-04-03 | IBRUTINIB | 02 | null | 310025400 | IFOSFAMIDE |
| 310010869 | 310005668 | null | null | Palliative (P) | 2017-12-14 | 2018-01-31 | ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 2 | N | 310025467 | INCA TRIAL |
| 310010870 | 310005673 | 1.65 | 66.9 | Adjuvant (A) | 2019-03-11 | 2019-03-29 | Capecitabine | N | N | 310025486 | INTERFERON |
| 310010871 | 310005679 | 1.55 | null | Curative (C) | 2015-05-16 | 2015-05-16 | RUXOLITINIB | N | null | 310025707 | ICON TRIAL |
| 310010872 | 310010049 | 1.78 | 113.8 | Curative (C) | 2012-10-25 | 2014-11-20 | Carboplatin + Docetaxel | N | N | 310025747 | OXALIPLATIN + MDG |
| 310010873 | 310005688 | null | null | null | 2020-04-19 | 2020-04-28 | Azacitidine | N | null | 310002637 | MVAC |
| 310010874 | 310005694 | 1.6 | 0 | Palliative (P) | null | 2016-12-26 | Carbo F | null | null | 310003715 | CEV |